Benitec Biopharma Inc. (BNTC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Benitec Biopharma Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$8.80
+1.38% today
Market cap
$303M
Overall quality
49/100
Kronos AI 30-day
+42.9%
8 of 8 simulated paths end higher
Benitec Biopharma Inc. (BNTC) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $303M. It trades at $8.80, up 1.38% today. Its overall quality score is 49 out of 100, ranked against the whole US market. 5 analysts' average target of $22.00 implies +150.0% from today's price. Kronos AI's 30-day forecast is +42.9% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $22.00 |
| Low – high | $14.00 – $32.00 |
| Analysts | 5 |
| Upside to average | +150.0% |
Kronos AI 30-day forecast
| Expected close | $12.41 (+42.9%) |
| Likely range | +32.2% … +53.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 41 |
| Solvency | 61 |
| Growth | 44 |
| Overall | 49 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.